110. In 2020, Moderna developed an effective mRNA-based vaccine against SARS-CoV-2. The mRNA causes the body to make viral proteins that then elicit a strong immune response. The vaccine consists of a suspension containing 0.20 mg/mL of the mRNA. The required dose of the mRNA is 100.0 μg. What volume of the vaccine suspension should be injected to achieve the required dose of mRNA?